See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 10, 2005

Healthy Patient Studies Ovarian Cancer Brain Metastases

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Healthy Patient Studies

The Substance Use Research Center at Columbia University seeks healthy marijuana smokers (age 21-45) to participate in residential studies evaluating marijuana effects. Live on a research unit at the NYS Psychiatric Institute for 23-25 days. You can earn approximately $1660. Research site located in New York, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Ovarian Cancer

UVa Health System Cancer Center seeks adult women with ovarian cancer to test whether an investigational ovarian cancer vaccine developed by the UVa Human Immune Therapy Center is effective. You may be eligible for this trial if you have Stage 3 or 4 ovarian cancer. Research site located in Charlottesville, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

Brain Metastases

EFAPROXYN is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases. Patients will need to return for four follow-up visits within six months after completion of treatment. Adult women with brain metastases from breast cancer may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat496.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.